Journal
CANCER DISCOVERY
Volume 9, Issue 10, Pages 1422-1437Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/2159-8290.CD-18-1259
Keywords
-
Categories
Funding
- NIH [CA185301, CA210087, CA068458, CA163205, NS106170, AI129582, CA223400]
- Leukemia and Lymphoma Society [6503-17, 1364-19]
- American Cancer Society Scholar Award [RSG-14-243-01-LIB]
- Gabrielle's Angel Cancer Research Foundation
- City of Hope
Ask authors/readers for more resources
Blockade of PD-L1 expression on tumor cells via anti-PD-L1 monoclonal antibody (mAb) has shown great promise for successful cancer treatment by overcoming T-cell exhaustion; however, the function of PD-L1 on natural killer (NK) cells and the effects of anti-PD-L1 mAb on PD-L1(+) NK cells remain unknown. Moreover, patients with PD-L1(-) tumors can respond favorably to anti-PD-L1 mAb therapy for unclear reasons. Here, we show that some tumors can induce PD-L1 on NK cells via AKT signaling, resulting in enhanced NK-cell function and preventing cell exhaustion. Anti-PD-L1 mAb directly acts on PD-L1(+) NK cells against PD-L1(-) tumors via a p38 pathway. Combination therapy with anti-PD-L1 mAb and NK cell-activating cytokines significantly improves the therapeutic efficacy of human NK cells against PD-L1(-) human leukemia when compared with monotherapy. Our discovery of a PD-1-independent mechanism of antitumor efficacy via the activation of PD-L1+ NK cells with anti-PD-L1 mAb offers new insights into NK-cell activation and provides a potential explanation as to why some patients lacking PD-L1 expression on tumor cells still respond to anti-PD-L1 mAb therapy. SIGNIFICANCE: Targeting PD-L1 expressed on PD-L1(+) tumors with anti-PD-L1 mAb successfully overcomes T-cell exhaustion to control cancer, yet patients with PD-L1(-) tumors can respond to anti-PD-L1 mAb. Here, we show that anti-PD-L1 mAb activates PD-L1(+) NK cells to control growth of PD-L1(-) tumors in vivo, and does so independent of PD-1.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available